Philippe H Lagrange - Academia.edu (original) (raw)

Papers by Philippe H Lagrange

PLoS ONE, 2014

Background: The aim of this multi-centric prospective study in India was to assess the accuracy o... more Background: The aim of this multi-centric prospective study in India was to assess the accuracy of a serological test as an additional tool for diagnosing active tuberculosis (ATB). In particular, an assay based on ELISA using a phenolic glycolipid (PGL-Tb1) or a fusion protein (ESAT-6/CFP10) was compared to the tuberculin skin test (TST) and the microbiological results according to HIV status.

Cellular Microbiology, 2007

Contrasting observations raise the question of the role of mycobacterial derived products as comp... more Contrasting observations raise the question of the role of mycobacterial derived products as compared with the whole bacterium Mycobacterium tuberculosis on maturation and function of human dendritic cells (DCs). DC-SIGN has been identified as the key DC receptor for M. tuberculosis through its interaction with the mannosylated lipoarabinomannan (ManLAM). Although ManLAM is a major mycobacterial component released from infected antigen-presenting cells, there is no formal evidence yet for an effect of ManLAM per se on DC maturation and function. DCs activated with purified ManLAM displayed an intermediate maturation phenotype as compared with lipopolysaccharide fully matured DCs with reduced expression of MHC class I and class II molecules, CD83 and CD86 and of the chemokine receptor CCR7. They were sensitive to autologous natural killer (NK) lysis, thus behaving like immature DCs. However,

Int J Immunopharmacol, 1985

Tests, exploring hallmarks of cell-mediated immunity (CMI), were used in order to compare immunog... more Tests, exploring hallmarks of cell-mediated immunity (CMI), were used in order to compare immunogenecity of same numbers of viable units from three different preparations of BCG vaccine derived from the same strain. Specific and non-specific cellular immune responses were assessed by several tests including, active and adoptive acquired resistance to Mycobacterium tuberculosis, local and systemic granuloma formation. BCG persistence in the spleen, delayed type hypersensibility (DTH) to tuberculin, immunopotentiation of DTH to sheep red blood cells, increase resistance to Listeria monocytogenes infection and occurrence of non-specific in vitro immunodepression. The ranking order of the three preparations concerning the active specific acquired resistance to tuberculosis did correlate well the ranking established for all immunopotency tests used in our study, however differences in acquired resistance were small as compared to differences observed for immunopotency tests. Moreover, adoptive transfer of same number of lymphoid cells from immune donors gave a different ranking order; the well dispersed fresh frozen (FF) vaccine being more able to induce higher adoptive protection as compared to the mechanically dispersed preparations. All these results clearly demonstrated that BCG could not be considered as single entity and that the test based on acquired resistance to M. tuberculosis or in vivo or in vitro hallmarks of CMI cannot be used as standard procedures.

Sexually transmitted diseases, 2002

Human herpesvirus 8 (HHV-8) is thought to be possibly sexually transmitted in some populations, b... more Human herpesvirus 8 (HHV-8) is thought to be possibly sexually transmitted in some populations, but few data are available on this mode of transmission. GOAL The goal was to study HHV-8 seroprevalence in patients attending a sexually transmitted disease (STD) clinic and to search for predictive factors of HHV-8 seropositivity. Five hundred twelve consecutive patients attending the STD clinic of Hôpital Saint-Louis (Paris) were tested for HHV-8 antibodies (immunofluorescence assay using two cell lines, BCP-1 and ISI n. butyrate [3 mmol/l]). A standardized questionnaire was used to obtain demographic, behavioral, and clinical data. Predictive factors of HHV-8 seropositivity were considered in univariate and multivariate analysis with use of logistic regression models. In testing of the patients for HHV-8 antibodies, 67/512 (13.1%) tested positive: 53/346 (15.3%) of men and 14/166 (8.4%) of women ( = 0.03). The predictive factors of HHV-8 seropositivity for men were the country of orig...

Actualites Gynecologiques, 1990

International Journal of Immunopharmacology, 1996

An explanation was sought for the fact that an enhancement of myocarditis occurs when Trypanosoma... more An explanation was sought for the fact that an enhancement of myocarditis occurs when Trypanosoma cruzi infected mice is treated with cyclophosphamide (CY). Several schedules were tested in mice and two polar models were achieved--one presenting parasite exacerbation without inflammatory reaction and the other presenting only cellular infiltrate in function of timing and different dosage of drug. In those receiving the drug after infection, an enhancement of the parasite load was detected and it was associated with an inflammatory reaction when mice were treated every other day with low doses of CY (3 mg/kg), but such inflammation was not present if a single dose of 200mg/kg was used 5 days after infection. On the other hand, in schedules using 200 mg/kg of CY 2 days before infection an enhancement of myocarditis was observed on day 12 post infection, but this was not associated with parasite proliferation. Finally when employing a single intermediate dose of 40mg/kg, a parasite load as well as a myocarditis enhancement was observed. A correlation between blood monocytes rebound and the intensity of myocarditis has been observed, and the varying time of drug injection suggested that this cellular infiltrate modulates the parasite load. If the immunosuppressive period of the drug occurred during parasite tissue invasion, parasite load amplification would occur without myocarditis.

Annales D Immunologie, 1979

Cellular Immunology, 1985

Annales De Microbiologie, Feb 1, 1978

Médecine et Maladies Infectieuses, 1990

The open respiratory medicine journal, 2008

Tuberculin skin testing (TST) and Interferon-gamma (IFNγ)release assays (IGRAs) are presently the... more Tuberculin skin testing (TST) and Interferon-gamma (IFNγ)release assays (IGRAs) are presently the only available assays for the detection of Mycobacterium tuberculosis infected individuals. IGRAs might progressively replace TST, as numerous published reports establish their higher specificity and similar sensitivity when tested in BCG vaccinated, immunocompetent individuals or in populations who may have been in contact with atypical mycobacteria. However, few published reports have commented on their role in TB diagnosis in immunocompromised individuals (HIV, immunosuppressive therapy, cancer...). It is the purpose of this report to review IGRAs published studies in HIV individuals in endemic and non endemic area for tuberculosis (TB). IGRAs were tested in the presence or absence of active TB but correlated to duration of exposure. In newly diagnosed active TB, IGRAs demonstrated a similar sensitivity to TST. In TB non infected individuals, TST and IGRAs also gave similar values wh...

La Presse Médicale, 2005

Still disappointing results from a seductive idea • Mucosal surfaces of the respiratory tract rep... more Still disappointing results from a seductive idea • Mucosal surfaces of the respiratory tract represent a major portal of entry for most human viruses and a critical component of the mammalian immunologic repertoire. The major antibody isotype in external secretions is secretory immunoglobin A (S-IgA). The major effector cells in mucosal surfaces, however, are not IgA B cells, but T lymphocytes, which may account for up to 80% of the mucosal lymphoid cell population. • Mucosal immunoprophylaxis is theoretically an important approach to control infections acquired through these portals. Passive antibodies can protect against mucosal viral infections, as shown for respiratory syncytial virus, but very high quantities of passive antibodies are needed to restrict virus replication on mucosal surface. • Factors likely to induce mucosal antibody and cell-mediated immune responses include oral or respiratory routes of immunization and active (effectively replicating) vaccine agents. • Very few antiviral vaccines have been developed to protect the mucosal surface of the respiratory tract, and only an attenuated influenza virus vaccine uses the nasal route. Other vaccines, approved for parenteral use, have been administered experimentally by the nasal route; these include active (replicating) and inactive (nonreplicating) vaccines. By this route they induce only a moderate local mucosal response. • Neither the development of mucosal immunity nor the administration of vaccines via the mucosal route is essential for control or prevention of most respiratory viral infections and diseases acquired through the respiratory tract. Nonetheless, the example of the live attenuated intranasal influenza vaccine, which induces both systemic and local immune response, is promising for the future of mucosal immunization against respiratory viral infections.

Annales de l'Institut Pasteur / Immunologie, 1985

As the prototype of a vaccine against mycobacterial infection, the BCG (bacille bili6 Calmette et... more As the prototype of a vaccine against mycobacterial infection, the BCG (bacille bili6 Calmette et Gu~rin) has been used against tuberculosis for more than 60 years. It is the only live attenuated vaccine used on humans in more than 182 countries or territories in the world, and very few changes have been made in its fabrication and distribution, except for the production of lyophilized seed-lots. However, its history is marked with controversies concerning its innocuity and efficacy. While BCG safety is no longer a matter of debate, the question of its effectiveness is still pertinent, and results in several controlled trials have shown great variability (from 0 to 80%). The studies of different variables involved in such results have shown statistical bias, and numerous factors are involved in the highly complex interrelationships between the host, the pathogen and environmental factors. World-wide research is now being conducted under the auspices of the World Health Organisation, in order to gain further knowledge of the immunology of tuberculosis and leprosy. Such results are aimed at understanding variations in BCG efficacy and producing strategies for developing new vaccines and alternative methods for prophylaxis and diagnosis. Concerning human infections due to other facultative intracellular multiplying bacteria, there are relatively few vaccines which are able to give long-lasting and efficient protection. Some controversy remains as to the live attenuated mutant GalE S. typhi Ty21a, and there is hope for the new insoluble phenol extract from Brucella abortis, strain B19. Further research is necessary on the others, for instance, Listeria monocylogenes, Chlamydia tracbomatis and Legionella sp.

Annales de l'Institut Pasteur / Immunologie, 1984

Delayed-type hypersensitivity (DTH) reactions induced with sheep red blood cells (1 X 10(8) SRBC/... more Delayed-type hypersensitivity (DTH) reactions induced with sheep red blood cells (1 X 10(8) SRBC/mouse) or with attenuated viable Mycobacterium bovis (4 X 10(6) BCG/mouse) inoculated subcutaneously and elicited, respectively, with SRBC or protein-purified derivative (PPD), were studied regularly in separate groups of outbred mice and compared during a period of one year following immunization. The present report shows the existence of two distinct types of DTH reactions. The SRBC type consists of a reaction which peaks consistently at 18 h, reaches a maximum 4 days after immunization, and decreases progressively until the fourth month. This local reaction, mediated by specific committed T cells as demonstrated by adoptive transfer experiments, was shown to consist mainly of a polymorphonuclear leukocyte infiltration. The PPD type consists of a local reaction which presents a different time course, the peak shifting from 18 to 42 h during the first two months after immunization, and which persists unchanged over a year after immunization. This second type of DTH reaction consisted of an early phase of polymorphonuclear infiltration followed by an increased number of mononuclear cells. Evidence is also given that the differences in the expression of these two types of DTH reactions depended neither upon the physical characteristics of the two antigens used for elicitation nor upon the nonspecific environmental modulating activity of BCG, since soluble SRBC protein and heat-killed BCG cells elicited the same distinct types, and the two distinct DTH reaction types could be elicited in mice immunized with both BCG and SRBC.

Médecine et Maladies Infectieuses, 1994

Pathologie Biologie, 2005

A new scenario has been unraveled recently--the interaction between the human dendritic cell (DC)... more A new scenario has been unraveled recently--the interaction between the human dendritic cell (DC) and Mycobacterium tuberculosis. Whether this encounter represents a defense mechanism by the invaded host, or a smoke screen, masking the presence of an invader is still unknown. The intracellular behavior of M. tuberculosis inside DCs differs compared to macrophages (Mphis), with a failure of replication. The intracellular compartment of the DC, disconnected from the exocytic and endocytic pathways, and characterized by the absence of endoplasmic reticulum and Golgi features, places M. tuberculosis in a hostile environment, where a ready source of nutrients is scarce. The differential behavior inside Mphis and DCs is linked to a different portal of entry. DCs harbor surface lectins receptors, like DC-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN/CD209), a binding site which is absent on Mphis. This receptor interacts exclusively with M. tuberculosis. The ligand is the mannose-capped lipoarabinomanan (LAM), absent from atypical mycobacteria. M. smegmatis, M. chelonae and M. fortuitum, which possess LAM capped with phosphoinositides residues, do not bind to DC-SIGN, demonstrating a role for DC-SIGN as a &amp;#39;pattern-recognition receptor&amp;#39; with the ability to differentiate between pathogenic and non-pathogenic mycobacteria. Interactions of M. tuberculosis with DC-SIGN have antiinflammatory effects. Whether this property is of benefit to the invader remains to be discovered.